Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-free synthesis for high-purity azaspiro compounds. Reduces cost and supply chain risk for pharmaceutical manufacturing.
Novel chiral spiro ammonium salt catalyst patent CN115197145B enables high-yield oxy-Cope rearrangement. Delivers superior enantioselectivity and scalable manufacturing for pharmaceutical intermediates.
Patent CN114195726B details a novel CuCl-catalyzed route for 1,2,4-triazolyl arylamines, offering significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN112125856A reveals a safe Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel metal-free synthesis method for trifluoromethyl selenium azaspiro compounds offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel chiral phosphoric acid catalyzed synthesis of axially chiral indole-naphthalene compounds with high enantioselectivity for pharmaceutical applications.
Novel synthesis route avoids expensive catalysts. High purity pharmaceutical intermediate. Cost-effective scale-up for global supply chains and procurement.
Patent CN114315609A discloses a novel 3-step process for cis-2-aminocyclohexanol from cyclohexene, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN113121462B reveals a metal-free, azide-safe route for 5-trifluoromethyl-1,2,3-triazoles, offering cost reduction in API manufacturing and scalable supply.
Patent CN113735778B reveals efficient Ag2O promoted synthesis. Delivers high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability.
Patent CN107663149A details a novel selenium-catalyzed route for phenanthrenequinone. Offers cost reduction in pharmaceutical intermediates manufacturing and high-purity output.
Patent CN112126941B reveals a green electrochemical route for 10-hydroxyphenanthrene derivatives, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN113683595B reveals sulfur-promoted route for high-purity pharmaceutical intermediates. Offers cost reduction and scalable manufacturing solutions.
Patent CN107629049A offers efficient pyrido isoindole synthesis. Low cost catalysts, air conditions, high yield for pharma intermediates.
Novel metal-free route for trifluoromethyl pyrazoles. Room temperature reaction ensures scalable, cost-effective pharmaceutical intermediate manufacturing with high purity standards.
Novel Rose Bengal catalyzed method for alpha-indole glycine derivatives offers green, scalable production for pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with reduced costs and scalable supply chain reliability for global pharma.
Novel Pd-catalyzed carbonylation method for 2-CF3 imidazoles. High yield, mild conditions, scalable pharma intermediate production.
Novel synthesis method offers high enantioselectivity and cost reduction for asymmetric MBH and cyclization reactions in pharmaceutical manufacturing.
Patent CN108864110B reveals a novel organocatalytic route for anticancer naphthoquinopyrans, offering improved safety and scalability for pharmaceutical intermediate manufacturing.